Clinical Trial Update: A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris [NA]

View source ↗

Summary

A completed bioequivalence study comparing Actavis Mid-Atlantic's Adapalene and benzoyl peroxide topical gel 0.1%/2.5% with Epiduo gel 0.1%/2.5% for acne vulgar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Adapalene and benzoyl peroxide topical gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) (adapalene and benzoyl peroxide topical gel)
• EPIDUO (adapalene and benzoyl peroxide)

Snippet

Sponsor: Actavis Mid-Atlantic LLC | Conditions: Acne Vulgaris | NA | Status: COMPLETED